Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03821 |
| Species: | Homo sapiens |
| Position : | chr12:9916938-9918379 |
| Year: | 2020 |
| Title: | Functional Characterization of a Dual Enhancer/Promoter Regulatory Element Leading Human CD69 Expression. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 33193627 |
| Tissue: | lymph node |
| Tissue Ontology ID: | UBERON:0000029 |
| Cell Source: | C1R B cells |
| Cell Type: | B cell |
| Cell Ontology ID: | CL:0000236 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay, TF binding assay; Enhancer activity assay; Endogenous enhancer perturbation |
| High Throughput Method: | RNA-seq, ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, ChIP-qPCR, RT-qPCR; CRISPR-Cas9 endogenous deletion/editing; Luciferase reporter assay |
| Target gene : | CD69 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03825 | chr12:9916938-9918379 | blood | T lymphoblast | NA |